Matthias Bodenstedt, Chief Financial Officer at MoonLake Immunotherapeutics (MLTX), bought 21,740 shares at $9.09 ($198K) on 2025-10-08, disclosed to the SEC on 2025-10-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.09 | 10,870 | $99K | 50.0% |
| 2 | $9.09 | 10,870 | $99K | 50.0% |
| Total | $9.09 avg | 21,740 | $198K | 100% |
| Filing → |
| MLTX | SELL | 2026-05-13 | $273K | — | Filing → |
| MLTX | SELL | 2026-04-16 | $47K | — | Filing → |
| MLTX | SELL | 2026-04-10 | $1.7M | — | Filing → |